GlassScriptPhysician profile
Lawrence I Kring
NPI 1962449025
$1,167.15
in general payments reported to CMS, 2019-2025
16 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.19 · 2020: $17.39 · 2021: $13.89 · 2022: $177 · 2023: $276 · 2024: $452 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $276.75 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $200.45 | 2022-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $141.75 | 2022-2025 | Airsupra, Farxiga |
| Gilead Sciences, INC. | $136.71 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $70.19 | 2019-2020 | |
| Exact Sciences Corporation | $61.58 | 2023-2025 | Cologuard Collection Kit |
| Kvk-Tech, INC. | $48.25 | 2024 | |
| Abbott Laboratories | $45.57 | 2023-2024 | Freestyle Libre 2 |
| Pfizer INC. | $43.09 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.91 | 2023 | Eliquis |
| Glaxosmithkline, LLC. | $27.13 | 2021-2022 | |
| Amgen INC. | $17.09 | 2024 | Otezla, Repatha |
| Dexcom, INC. | $16.40 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.04 | 2023 | Jynarque |
| Abbvie INC. | $14.17 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $13.07 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Kring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.